The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2025
Filed:
Feb. 25, 2025
Applicant:
Amunix Pharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Viktoriya Dubrovskaya, San Francisco, CA (US);
Eric Johansen, Oakland, CA (US);
Lucas Liu, San Bruno, CA (US);
Darragh Maccann, Magherfelt, GB;
Volker Schellenberger, Palo Alto, CA (US);
Milton To, San Lorenzo, CA (US);
Assignee:
Amunix Pharmaceuticals, Inc., South San Francisco, CA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3069 (2013.01); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2319/50 (2013.01);
Abstract
The disclosure describes antigen-binding molecules with binding specificity to cluster of differentiationT cell receptor (CD), antigen-binding molecules with binding specificity to prostate-specific membrane antigen (PSMA), cleavable linker sequences, and protease-activatable bispecific fusion proteins such as protease-activatable T cell engagers, as well as uses and methods of treatment.